Search research articles
Contact Us
Filters
Showing results (661-670 of 673) with videos related to
Page
of 68
Sort By:
Deutsche Medizinische Wochenschrift (1946)
|
November 9, 2001
[Epidemiology and interventional treatment strategies of infectious complications after allogenic stem-cell transplantation]
H Einsele, H Bertz, J Beyer, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
April 12, 1996
[10 years transplantation of bone marrow and hematopoietic stem cells in adults at the Hannover Medical School]
H Link, H Diedrich, L Arseniev, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
May 23, 2002
Association of time to recurrence with thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression in stage II and III colorectal cancer
Marko Kornmann, Karl H Link, Inga Galuba, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 11, 2007
Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015
C-H Köhne, J De Greve, J T Hartmann, et al.
Blood
|
August 10, 1999
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group
P Fenaux, C Chastang, S Chevret, et al.
British Journal of Haematology
|
December 21, 2000
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial
S De Botton, S Chevret, M Sanz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2018
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
C Röllig, M Kramer, M Gabrecht, et al.
Zentralblatt Fur Chirurgie
|
June 20, 2008
[Diagnosis and treatment of colorectal liver metastases - workflow]
R T Grundmann, P Hermanek, S Merkel, et al.
Leukemia
|
November 3, 2015
Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the Study Alliance Leukemia
C Müller-Tidow, P Tschanter, C Röllig, et al.
Leukemia
|
August 15, 2017
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
R Hehlmann, M Lauseker, S Saußele, et al.
Page
of 68
Search research articles
Search
Showing results (661-670 of 673) with videos related to
Sort By:
Page
of 68
Deutsche Medizinische Wochenschrift (1946)
|
November 9, 2001
[Epidemiology and interventional treatment strategies of infectious complications after allogenic stem-cell transplantation]
H Einsele, H Bertz, J Beyer, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
April 12, 1996
[10 years transplantation of bone marrow and hematopoietic stem cells in adults at the Hannover Medical School]
H Link, H Diedrich, L Arseniev, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
May 23, 2002
Association of time to recurrence with thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression in stage II and III colorectal cancer
Marko Kornmann, Karl H Link, Inga Galuba, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 11, 2007
Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015
C-H Köhne, J De Greve, J T Hartmann, et al.
Blood
|
August 10, 1999
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group
P Fenaux, C Chastang, S Chevret, et al.
British Journal of Haematology
|
December 21, 2000
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial
S De Botton, S Chevret, M Sanz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2018
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
C Röllig, M Kramer, M Gabrecht, et al.
Zentralblatt Fur Chirurgie
|
June 20, 2008
[Diagnosis and treatment of colorectal liver metastases - workflow]
R T Grundmann, P Hermanek, S Merkel, et al.
Leukemia
|
November 3, 2015
Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the Study Alliance Leukemia
C Müller-Tidow, P Tschanter, C Röllig, et al.
Leukemia
|
August 15, 2017
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
R Hehlmann, M Lauseker, S Saußele, et al.
Page
of 68